MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing

NCT02006069 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
5850
Enrollment
INDUSTRY
Sponsor class

Stopped The steering committee had decided to discontinue enrollment because the interim analysis showed a low probability that the study would meet the primary endpoint. The interim analysis did not demonstrate any safety concerns with activating MPP.

Conditions

Interventions

Sponsor

Abbott Medical Devices